Skip to content

A randomised clinical trial on comprehensive geriatric assessment and intensive follow up after hospital discharge: The transitional care bridge.

A randomised clinical trial on comprehensive geriatric assessment and intensive follow up after hospital discharge: The transitional care bridge.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22311
Enrollment
674
Registered
2010-06-23
Start date
2010-07-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

internal medicine, geriatric conditions, geriatric syndromes, multimorbidity

Interventions

The intervention group will receive the transitional care bridge program, consisting of a handover moment with a community care nurse (CN) during hospital admission and five home visits after discharg

Sponsors

Academic Medical Center, Amsterdam, the Netherlands Flevo Hospital Almere, the Netherlands OLVG, Amsterdam, The Netherlands Flevo Hospital Hospitaalweg 1 1315 RA Almere The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Acutely admitted on the department of internal medicine; 2. 65 years and older; 3. Hospitalized for at least 48 hours; 4. At increased risk for functional decline.

Exclusion criteria

Exclusion criteria: 1. Terminally ill; 2. No dutch language capabilities; 3. Transferred to the Intensive care unit or other department within 48 hours after admission.

Design outcomes

Primary

MeasureTime frame
Main outcome is the level of ADL functioning six months after discharge compared to premorbid functioning measured with the Katz ADL index.

Secondary

MeasureTime frame
Secondary outcomes include survival, cognitive functioning, quality of life, health care utilization, satisfaction of the patient and primary care giver with the transitional care bridge program.

Contacts

Public ContactBianca Buurman

Postbus 22660

b.m.vanes@amc.nl+31 (0)20 5665991

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)